Therefore, TRPA1 was recently intensively investigated in different central nervous system pathologies, e.g., multiple sclerosis (Sághy et al. 2016; Bölcskei et al. 2018) and Alzheimer’s disease (Lee et al. 2016). Here, TRPA1 is linked to Alzheimer disease.